ZA987662B - Neospora Vaccine. - Google Patents

Neospora Vaccine.

Info

Publication number
ZA987662B
ZA987662B ZA9807662A ZA987662A ZA987662B ZA 987662 B ZA987662 B ZA 987662B ZA 9807662 A ZA9807662 A ZA 9807662A ZA 987662 A ZA987662 A ZA 987662A ZA 987662 B ZA987662 B ZA 987662B
Authority
ZA
South Africa
Prior art keywords
neospora vaccine
neospora
vaccine
Prior art date
Application number
ZA9807662A
Other languages
English (en)
Inventor
David Alan Brake
Manuel Campos
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22007613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA987662(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA987662B publication Critical patent/ZA987662B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA9807662A 1997-08-26 1998-08-25 Neospora Vaccine. ZA987662B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5695697P 1997-08-26 1997-08-26

Publications (1)

Publication Number Publication Date
ZA987662B true ZA987662B (en) 2000-02-25

Family

ID=22007613

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9807662A ZA987662B (en) 1997-08-26 1998-08-25 Neospora Vaccine.

Country Status (16)

Country Link
US (2) US6787146B2 (zh)
EP (2) EP1477184A3 (zh)
JP (1) JP3049016B2 (zh)
CN (1) CN1211449A (zh)
AR (1) AR016396A1 (zh)
AT (1) ATE277631T1 (zh)
AU (1) AU764455B2 (zh)
BR (1) BR9803232A (zh)
CA (1) CA2245425C (zh)
DE (1) DE69826593T2 (zh)
DK (1) DK0898969T3 (zh)
ES (1) ES2227783T3 (zh)
NZ (1) NZ331529A (zh)
PT (1) PT898969E (zh)
TW (2) TWI228419B (zh)
ZA (1) ZA987662B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812976A (pt) 1997-10-20 2000-08-08 Bayer Ag Vacina de neospora
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
ME00810B (me) * 2002-08-26 2012-03-20 Zoetis Services Llc Vakcina za infekcije respiratornog i reproduktivnog sistema kod stoke
AU2003301526A1 (en) * 2002-10-25 2004-05-13 University Of Connecticut Health Center Immunotherapy of cancer through controlled cell lysis
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
CN101831495B (zh) * 2010-04-30 2013-06-19 新疆出入境检验检疫局检验检疫技术中心 一种牛新孢子虫病的检测方法及应用
EP2708237A1 (en) * 2012-09-17 2014-03-19 Université de Droit et de la Santé de Lille 2 Pharmaceutical composition for its use in the preventive treatment of infections caused by an intracellular pathogen, more particularly Toxoplasma gondii
WO2014182872A1 (en) 2013-05-08 2014-11-13 Protatek International, Inc. Vaccine for pcv2 and mycoplasma
EP3368070B9 (en) 2015-10-28 2023-10-18 Universidad Complutense De Madrid Neospora vaccine composition
JP2019533995A (ja) 2016-10-05 2019-11-28 ゾエティス・サービシーズ・エルエルシー 強力な生ワクチンとして使用するための安定に脱水された原生動物を提供する凍結乾燥方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5707617A (en) * 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6743430B1 (en) 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
AU7677896A (en) 1995-11-09 1997-05-29 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
ES2224210T3 (es) * 1996-11-12 2005-03-01 Pfizer Inc. Vacuna de neospora viva atenuada.

Also Published As

Publication number Publication date
DE69826593T2 (de) 2005-02-10
DK0898969T3 (da) 2005-01-17
BR9803232A (pt) 2000-01-11
JPH11130683A (ja) 1999-05-18
AU764455B2 (en) 2003-08-21
EP0898969A2 (en) 1999-03-03
AR016396A1 (es) 2001-07-04
EP1477184A3 (en) 2006-04-12
US20020058046A1 (en) 2002-05-16
CA2245425A1 (en) 1999-02-26
TW200305433A (en) 2003-11-01
DE69826593D1 (de) 2004-11-04
ATE277631T1 (de) 2004-10-15
EP1477184A2 (en) 2004-11-17
US20040223982A1 (en) 2004-11-11
EP0898969A3 (en) 2001-02-07
AU8188498A (en) 1999-03-11
EP0898969B1 (en) 2004-09-29
PT898969E (pt) 2005-01-31
TWI228419B (en) 2005-03-01
CN1211449A (zh) 1999-03-24
CA2245425C (en) 2006-12-12
US6787146B2 (en) 2004-09-07
ES2227783T3 (es) 2005-04-01
NZ331529A (en) 1999-03-29
JP3049016B2 (ja) 2000-06-05

Similar Documents

Publication Publication Date Title
ZA9811849B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
GB9726555D0 (en) Vaccine
CY2410B1 (en) Novel device.
HK1016976A1 (en) Resorcinyl-triazine.
ZA981926B (en) Detergent--package combination.
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
ZA978799B (en) Mycosis vaccine.
ZA987662B (en) Neospora Vaccine.
HK1017834A1 (en) Bodyshaper.
ZA983705B (en) Pregnan-3-ol-20-ones.
HK1016333A1 (en) Kara-ok device.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA982763B (en) Vaccines
ZA981309B (en) 4-aminoalkoxy-1H-benzoimidazoles.
ZA983795B (en) Substituted 4-benzoyl-pyrazoles.
ZA983532B (en) Sensors.
ZA98263B (en) O-fucosyltransferase.
ZA983698B (en) Estrenes.
ZA987303B (en) Vaccine.